Skip to main content
. Author manuscript; available in PMC: 2014 Jul 28.
Published in final edited form as: Urol Oncol. 2011 Jul 27;30(6):804–812. doi: 10.1016/j.urolonc.2011.02.002

Table 2.

Descriptive statistics of demographic and clinical characteristics by treatment type

Characteristics Prostatectomy
(n = 146, 16.8%)
EBRT
(n = 483, 55.6%)
Brachytherapy
(n = 240, 27.6%)
Full Sample
(N = 869)
X2/F p

Age (Mean ±SD) 58.38±6.70a 67.24±6.91b 66.16±6.84b 65.45±7.57 95.14 .001
PSA Level (Mean ±SD) 5.99±3.41a 8.77±8.59b 6.13±4.27c 7.53±7.08 14.724 .001
Gleason Score (Mean ±SD) 6.14±.70a 6.40±.86b 6.01±.37a 6.3±0.8 21.04 .001
Received neo-adjuvant/adjuvant 6.8% 12.6% 16.2% 13% 7.25 .03
Education:
   ≤High School 47.2% 48.1% 59.6% 51.1% 1.93 .38
   ≥College 52.8% 51.9% 40.4% 48.9%
Marital Status:
   Married/with partner 78.8% 82% 83.3% 81.8% 1.29 .52
   Single/Widowed/Divorced 21.2% 18% 16.7% 18.2%
Race
   Caucasian 90.4% 89.9% 92.1% 90.6% 10.43 .23
   African American 8.2% 7.9% 5.8% 7.4%
   Hispanic 1.4% .8% 1.7% 1.2%
   Asian/Other 0% 1.4% 0.4% .9%
Employment
   Employed 69.9% 33.5% 30.4% 57.6% 72.07 .001
   Not employed/retired 30.1% 66.5 69.6% 42.4%

Note. Different letters indicate significant differences between groups. Similar letters indicate the lack of significant differences between groups. Total sample is not included in statistical comparisons between the three treatment groups; surgery, radiation, and brachytherapy.